论文信息 - A feasibility study of gefitinib in association with capecitabine (CAP) and oxaliplatin (OXA) as first-line treatment in patients with advanced colorectal cancer (ACRC) - 字舞流文

A feasibility study of gefitinib in association with capecitabine (CAP) and oxaliplatin (OXA) as first-line treatment in patients with advanced colorectal cancer (ACRC)

F. Costanzo | A. Gabriele | F. Cognetti | V. Ferraresi | C. Nardoni | T. Gamucci | A. Gelibter | M. Zeuli | C. Signorelli | C. F. Pollera | Massimo Zeuli | C. F. Pollera